Parenteral formulation of zopiclone

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 1, 2008, Pages 99-102

  Swamy, P ^a   Sushma, P ^a   Chirag, G ^a   Prasad, K ^a   Ali, M ^a   Raju, S ^a  

^a HKES's College of Pharmacy   (India)

Author keywords

Accelerated stability; Parenteral formulation; Shelf life; Solubility enhancement; Zopiclone

Indexed keywords

HYPNOTIC SEDATIVE AGENT; SOLVENT; ZOPICLONE;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG DEGRADATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; HYDROPHILICITY; MOUSE; NONHUMAN; SEDATION; SHELF LIFE; THERMODYNAMICS; THERMOSTABILITY;

EID: 43449127221     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.40342     Document Type: Article

References (6)

1. British Pharmacopoeia: Published on the recommendation of Medicines Commission, U.K., London: Her Majesty's Stationery Office; 1993(Addendum 1996). p. 1848-9.
2. Santhosh RK, Shobha M, Appala Raju S. Visible spectrophotometric methods for estimation of zopiclone from bulkdrug and formulations. Asian J Chem 2000;12:449-52.
3. Lyne Bighley D, Stephen Berge M, Monkhouse Donald C, Swarbrick J. editors. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker Inc; 2002. p. 452.
4. Forbes RT, York P, Fawcett V, Shields L. Physicochemical properties of salts of p-aminosalicylic acid. Part I: Correlation of crystal structure and hydrate stability. Pharm Res 1992;9:1428-35.
5. Gourishankar D, Reddy MN, Rajendra Kumar JM, Srikanth K. Spectrophotometric determination of zopiclone. East Pharmacist 2000;43:149-50.
6. Lawrence DR, Bacharach AL, editors. Evaluation of drug activities and pharmacometrics. Vol. I. London: Academic Press; 1964. p. 160-1.